MTM(SH:688029) Sou Hu Cai Jing·2025-06-16 10:13Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Nanwei Medical, which has a current stock price of 65.72 yuan and a market capitalization of 12.345 billion yuan, with a rolling PE ratio of 21.63 times [1] - The medical device industry has an average PE ratio of 49.56 times and a median of 36.18 times, placing Nanwei Medical at the 49th position in the industry ranking [1][2] - As of the first quarter of 2025, 17 institutions hold shares in Nanwei Medical, including 11 funds, with a total shareholding of 106.4733 million shares valued at 7.017 billion yuan [1] Group 2 - Nanwei Medical specializes in the research, development, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, EMR/ESD, dilation, ERCP, EUS/EBUS devices, ablation instruments, disposable imaging systems, and related consumables [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 699 million yuan, a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also reflecting a year-on-year increase of 12.18%, with a gross profit margin of 65.69% [1]